Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04524104 · ClinicalTrials.gov registry record · NA
Study of a PST-Trained Voice-Enabled Artificial Intelligence Counselor (SPEAC) for Adults With Emotional Distress (Phase 1)
A NA study of Depression and Anxiety, sponsored by University of Illinois at Chicago.
- Completed
- Registry status
- NA
- Development phase
- 63
- Enrollment target
- 2
- Study locations
NCT04524104 is a NA study of Depression and Anxiety that has completed, run by University of Illinois at Chicago. The registered enrollment target is 63 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (92% lower). The trial reports 2 study locations across 1 state.
The verdict
NCT04524104, a NA study of Depression and Anxiety, has completed, sponsored by University of Illinois at Chicago.
- COMPLETED
- Registry status
- NA
- Development phase
- 63 participants
- Enrollment target
- 2
- Study locations
Study Summary
In the phase 1 of the SPEAC project the specific aims are to: (1) establish the functionality, usability, and treatment fidelity of Lumen using iterative, user-centered design, development, and formative evaluation; and (2) demonstrate feasibility, acceptability, and target engagement in a 2-arm pilot RCT. The aim 1 focuses on developing a voice-enabled, artificial intelligence (AI) virtual agent, named Lumen, trained in Problem Solving Therapy (PST) via an iPad-based application. The development of Lumen will employ iterative user-centered design-evaluation cycles. After the functionality, usability and treatment fidelity of Lumen are established, in the aim 2, we will conduct a 2-arm randomized clinical trial (RCT, Study 1) to pilot test Lumen.
Conditions Studied
Interventions
- BEHAVIORAL Lumen Treatment
Study Locations (2)
Illinois
- Department of Medicine, Vitoux Program on Aging and Prevention - Chicago
- UIMC Advanced Imaging Center - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 63 participants |
| Start Date | 2021-04-05 |
| Est. Completion | 2022-03-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04524104
The ClinicalTrials.gov registry entry for NCT04524104 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 63 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 786-participant average among 679 other Depression trials with a reported enrollment target (92% lower). The listed sponsor is University of Illinois at Chicago, which has 430 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Depression appearing as the primary indexed condition, and to 1 intervention - of which Lumen Treatment is the first listed.
NCT04524104 reports 2 study locations spanning 1 distinct geographic area - top geographies include Illinois.
Frequently Asked Questions
What is clinical trial NCT04524104 about?
NCT04524104 is a clinical study titled "Study of a PST-Trained Voice-Enabled Artificial Intelligence Counselor (SPEAC) for Adults With Emotional Distress (Phase 1)". In the phase 1 of the SPEAC project the specific aims are to: (1) establish the functionality, usability, and treatment fidelity of Lumen using iterative, user-centered design, development, and formative evaluation; and (2) demonstrate feasibility, acceptability, and target engagement in a 2-arm pil...
What is the current status of trial NCT04524104?
This trial is currently completed. It is a NA study. The enrollment target is 63 participants. The study started on 2021-04-05. Estimated completion is 2022-03-05.
What conditions does trial NCT04524104 study?
This clinical trial studies the following conditions: Depression, Anxiety.
What interventions are being tested in trial NCT04524104?
The interventions under investigation include: Lumen Treatment (BEHAVIORAL).
Who is sponsoring clinical trial NCT04524104?
This trial is sponsored by University of Illinois at Chicago, which has 430 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04524104 being conducted?
This trial has 2 study locations across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Depression
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Reaching Out to Distressed Medical Residents, Fellows and Faculty
RECRUITING · NA
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
Cold and Heat Investigation to Lower Levels of Depression
RECRUITING · NA
-
Dosing rTMS for Depression Post-SCI
RECRUITING · NA
-
Exploring Virtual Reality Adventure Training Exergaming
RECRUITING · NA
-
Brief Interventions for Coping with Distress
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.